Hydromer Reports Strategic Investment by JMEDTECH, and Formation of Its New Board of Directors
Summary
Hydromer says jMedtech made a strategic investment in the company and the two firms are building a broader global medical device coating platform. The partnership combines coating systems, equipment, and regional services to support R&D, validation, and mass production for customers worldwide. Hydromer also announced a refreshed board of directors, with Michael Torti continuing as CEO and director. The company says the move expands its reach across Asia and the Americas and strengthens supply chain resilience and customer responsiveness.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected